Mount Sinai DoctorsTreats Adults
Accepting New Patients
Cesar Rodriguez Valdes, MD
Cesar Rodriguez (Preferred Name)
Hematology-Oncology, Cancer (Oncology)
About Me
Dr. Cesar Rodriguez is Associate Professor of Medicine (Hematology and Medical Oncology) at the Icahn School of Medicine at Mount Sinai, The Tisch Cancer Institute, and the Center of Excellence for Multiple Myeloma, and serves as Clinical Director of Multiple Myeloma at The Mount Sinai Hospital. Dr. Rodriguez has extensive experience treating patients with plasma cell disorders including multiple myeloma, AL amyloidosis, POEMS syndrome, plasma cell leukemia, and monoclonal gammopathy of undetermined significance (MGUS). He is a member of the International Myeloma Working Group which conducts collaborative research and produces consensus guidelines for the myeloma community.
Dr. Rodriguez has more than 10 years of experience in clinical research and is the principal investigator of numerous clinical trials for multiple myeloma focused on early drug development and immunotherapies that include T cell and NK cell directed therapies. He also is working on a 3D organoid model to better understand the biology of the tumor niche.
Dr. Rodriguez speaks English, Spanish, French, and Italian.
He is on Twitter, @myleomatips
Language
Position
Hospital Affiliations
- Mount Sinai Morningside
- Mount Sinai Beth Israel
- Mount Sinai Brooklyn
- Mount Sinai Queens
- The Mount Sinai Hospital
- Mount Sinai West
About Me
Dr. Cesar Rodriguez is Associate Professor of Medicine (Hematology and Medical Oncology) at the Icahn School of Medicine at Mount Sinai, The Tisch Cancer Institute, and the Center of Excellence for Multiple Myeloma, and serves as Clinical Director of Multiple Myeloma at The Mount Sinai Hospital. Dr. Rodriguez has extensive experience treating patients with plasma cell disorders including multiple myeloma, AL amyloidosis, POEMS syndrome, plasma cell leukemia, and monoclonal gammopathy of undetermined significance (MGUS). He is a member of the International Myeloma Working Group which conducts collaborative research and produces consensus guidelines for the myeloma community.
Dr. Rodriguez has more than 10 years of experience in clinical research and is the principal investigator of numerous clinical trials for multiple myeloma focused on early drug development and immunotherapies that include T cell and NK cell directed therapies. He also is working on a 3D organoid model to better understand the biology of the tumor niche.
Dr. Rodriguez speaks English, Spanish, French, and Italian.
He is on Twitter, @myleomatips
Language
Position
Hospital Affiliations
- Mount Sinai Morningside
- Mount Sinai Beth Israel
- Mount Sinai Brooklyn
- Mount Sinai Queens
- The Mount Sinai Hospital
- Mount Sinai West
